ESAB Q3 2026 Earnings: Record Sales Contrast with Lower GAAP Profit

ESAB Corporation (NYSE: ESAB) reported Q3 2026 net sales of $824.5 million, up 13.3% year over year, while GAAP diluted EPS from continuing operations fell to $0.61 from $1.04. Core organic sales grew 2.3%, and core adjusted EBITDA increased 17.0% to $156.1 million as its margin expanded to 19.8%. The quarter ended October 2, 2026, showed a clear divide between higher adjusted profitability and lower GAAP earnings.

Core Earnings Data

Reported sales growth substantially exceeded the 2.3% core organic increase, a measure that excludes acquisitions, currency translation, and Russia. Gross profit grew faster than revenue, producing a higher GAAP gross margin, but operating income and net income declined as selling and administrative, restructuring, acquisition-related, and interest costs increased.

Adjusted results were more stable. Core adjusted net income rose 3.1%, although core adjusted EPS declined slightly to $1.30, while core adjusted EBITDA grew faster than sales.

Core adjusted measures exclude Russia and several items including restructuring, acquisition-related costs, intangible amortization, acquired-inventory fair value adjustments, and certain other expenses.

Business and Segment Performance

ESAB reported core organic growth in both the Americas and EMEA & APAC, although it did not disclose each segment’s organic growth rate. The two segments produced nearly identical core adjusted EBITDA margins, with EMEA & APAC contributing the larger amount of core adjusted EBITDA.

Management highlighted the acquisitions of EWM and Eddyfi as additions that expand ESAB’s offerings across cutting, welding, inspection, monitoring, and repair. It also said cross-selling opportunities between ESAB and Eddyfi were beginning to generate new growth.

Acquisition-Led Growth Widened the GAAP-Adjusted Profit Gap

ESAB’s gross profit increased by $54.3 million, but selling, general and administrative expense rose by $62.0 million to $220.4 million. Restructuring charges also increased to $11.3 million from $4.3 million, causing operating income to fall despite higher sales and gross margin.

Acquisition-amortization and related charges reached $39.9 million, compared with $16.5 million a year earlier. The latest quarter included $8.8 million of transaction, diligence, and integration expenses and $31.2 million of intangible amortization and acquired-inventory fair value adjustments. These costs help explain why core adjusted EBITDA increased while GAAP operating income and EPS declined.

Interest expense and other items added further pressure, rising to $36.5 million from $23.6 million. Continued inflation was another operating challenge, although management credited its EBXai operating system and execution initiatives with supporting adjusted margin expansion.

Full-Year 2026 Guidance

ESAB narrowed its expected total core sales growth range but lowered its core organic growth, core adjusted EBITDA, and core adjusted EPS forecasts. Higher expected M&A and foreign-exchange contributions are supporting reported growth, while the weaker organic outlook points to more modest underlying expansion.

The revised ranges suggest that acquisitions and currency will account for a greater share of full-year sales growth than previously expected, while underlying organic growth and adjusted profit will be lower than the company’s earlier forecast.

Management’s View

President and CEO Shyam P. Kambeyanda said ESAB improved sales, margins, and cash generation sequentially, though the release did not provide quarterly cash-flow figures. Management attributed the adjusted margin improvement to disciplined execution, growth investments, and EBXai, while emphasizing new products and the broader workflow capabilities added through EWM and Eddyfi.

Recent Insider Transactions

The provided insider data categorized the last six months as 21,390 shares purchased across 10 transactions and 1,000 shares sold in one transaction, resulting in net purchases of 20,390 shares. The detailed records include one reported sale, one derivative-security conversion, and two stock awards; these transactions do not by themselves establish insiders’ views on ESAB’s outlook.

Risks Investors Need to Watch

• Slower underlying growth: ESAB reduced its full-year core organic sales growth outlook to 1.6%–2.0%, making reported growth more dependent on acquisitions and currency.
• Acquisition and restructuring expenses: Elevated integration, amortization, acquired-inventory, and restructuring costs could continue to create a sizable gap between GAAP and adjusted profitability.
• Higher interest costs: Interest expense and other items increased materially year over year, adding pressure below the operating-income line.
• Inflationary pressure: Management said inflation remained a challenge, even as adjusted margins expanded during the quarter.
• Integration execution: ESAB’s strategy depends in part on integrating EWM and Eddyfi and converting expanded capabilities into cross-selling and sustainable organic growth.

Summary

ESAB delivered record Q3 sales, organic growth in both segments, and higher core adjusted EBITDA margins. However, acquisition-related expenses, restructuring, higher administrative costs, and increased interest expense drove lower GAAP operating income and EPS. The main forward-looking issue is whether ESAB can translate its acquired businesses and cross-selling initiatives into stronger organic growth, particularly after lowering its full-year organic sales and adjusted profit outlooks.